Hearing Implants MarketThe global hearing implant market is estimated to be valued at USD 1,402.1 million in 2023 and is ...

The global hearing solutions corporation Demant Korea (CEO Park Jin-kyun) announced that its premium brand Oticon ...

JPMorgan lowered the firm’s price target on Demant (WILYY) to DKK 306 from DKK 319 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for real-time ...

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare ...

However, the company noted a significant share loss in the Managed Care segment due to its brand strategy, which was only partially offset by the positive adoption of Oticon Intent in the independent ...

Oticon Intent is a rechargeable mini ride with ... so we typically replaced what was typically a third-party product with the Demant product. So, we will sell in additional from the hearing ...

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices ...

which was only partially offset by the positive adoption of Oticon Intent in the independent channel. For fiscal year 2024, Demant reached the low-end of its guidance with a 2.0% organic sales ...